Publication year: 2011 Source: Journal of Microbiological Methods, Available online 24 December 2011 B.J. Moncla, K. Pryke, L.C. Rohan, H. Yang The development of topical microbicides for intravaginal use to prevent HIV infection requires that the drugs and formulated products be nontoxic to the endogenous vaginalLactobacillus. In 30 min exposure tests we found dapivirine, tenofovir and UC781 (reverse transcriptase inhibitor anti-HIV drugs) as pure drugs or formulated as film or gel products were not deleterious toLactobacillusspecies; however, PSC-RANTES (a synthetic CCR5 antagonist) killed 2 strains ofLactobacillus jensenii.
Testing of viscous anti-HIV microbicides usingLactobacillus
- Retinoids and Skin: Anti-Inflammatory and Pro-Happy Feet?
- Anti-ischemic effects of multivalent dendrimeric A3adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heart
- Use of an Anti-gravity Treadmill in the Rehabilitation of the Operated Achilles Tendon: A Pilot Study
- Bugs and Drugs 2011 (Slide Show)
- Foot fractures in HIV infected patients
- The investigation of (Bi,La)(Ga,Fe)O3–PbTiO3thin film prepared by PLD technique
- Removal of Osteoid Osteoma of the Tibia Using Two-portal Posterior Ankle Arthroscopy
- Reliability of a basketball specific testing protocol for footwear fit and comfort perception
- Eighteen years of running shoe testing in Germany – a series of biomechanical studies
- Discovering theorems in game theory: Two-person games with unique pure Nash equilibrium payoffs